GlaxoSmithKline

مادة اعلانية

Latest Update: 13 Jan 2026 15:58 Abu Dhabi Time.

Market Status: Opened

BIOC

GlaxoSmithKline

61.55

EGP

-0.200

-0.32%

Open

61.75

Prev Close

61.75

PX_VOLUME

22,966

MARKET CAP (M)

DAY RANGE

61.50 - 62.50

52 WEEKS

32.66 - 81.50

Stock Statistics

Yearly Change

61.36%

Listed Shares (Million)

83.51

Earnings Multiple

53.43

Average 30-day trading volume

132,483.62

Price-to-book ratio

2.58

Earnings Per Share

2.08

Previous Dividend Distribution

0.95

Dividend Yield

1.59%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		1,008.13	890.98	993.91	847.49	787.08	642.45	713.81	663.47	576.44
Gross Profit		105.01	173.49	302.22	271.80	175.96	330.14	326.35	459.45	170.45
Operating Income		-77.68	12.77	97.92	129.25	81.65	132.86	76.32	291.41	105.17
Profit Margin		-3.46	0.67	5.95	8.04	1.69	15.81	-1.26	2.07	4.71

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		2,990.82	2,240.22	1,817.67	1,014.99	1,992.83
Gross Profit		1,104.25	843.33	572.53	307.04	779.84
Operating Income		420.08	440.90	18.94	11.49	202.51
Profit Margin		5.82	2.70	-6.26	-6.74	1.41

Balance Sheet

	Period Ending:	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		4,530.84	4,873.60	4,613.67	3,652.63	3,712.12	3,744.61	3,971.75	3,557.92	3,557.41
Total Liabilities		2,496.56	2,858.74	2,504.73	1,657.08	1,784.72	1,830.48	2,089.49	1,592.59	1,605.81
Total Equity		2,034.28	2,014.86	2,108.94	1,995.56	1,927.40	1,914.13	1,882.26	1,965.33	1,951.60

	Period Ending:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		3,652.63	3,557.92	3,185.07	2,424.75	2,117.34
Total Liabilities		1,657.08	1,592.59	1,456.63	1,066.79	904.25
Total Equity		1,995.56	1,965.33	1,728.43	1,357.96	1,213.10

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.